tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LXEO Stock Latest News

Lexeo Therapeutics Appoints Dr. Kyle Rasbach as CFO
Company AnnouncementsLexeo Therapeutics Appoints Dr. Kyle Rasbach as CFO
1d ago
8K
LXEO
Lexeo Therapeutics appoints Rasbach as Chief Financial Officer
PremiumThe Fly
Lexeo Therapeutics appoints Rasbach as Chief Financial Officer
1d ago
LXEO
ZNTL
Lexeo Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Lexeo Therapeutics files $300M mixed securities shelf
7d ago
LXEO
Four new option listings and one option delisting on December 10th
PremiumThe Fly
Four new option listings and one option delisting on December 10th
10d ago
TCS
INGM
Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report
PremiumCompany Announcements
Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report
1M ago
LXEO
Lexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright
PremiumThe FlyLexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright
1M ago
LXEO
Lexeo Therapeutics price target raised to $25 from $23 at Chardan
Premium
The Fly
Lexeo Therapeutics price target raised to $25 from $23 at Chardan
1M ago
LXEO
Lexeo Therapeutics price target lowered to $19 from $20 at Leerink
Premium
The Fly
Lexeo Therapeutics price target lowered to $19 from $20 at Leerink
1M ago
LXEO
Lexeo Therapeutics Strengthens Leadership with New Board Appointment
PremiumCompany Announcements
Lexeo Therapeutics Strengthens Leadership with New Board Appointment
1M ago
8K
LXEO
Lexeo Therapeutics reaches FDA alignment on development plan for LX2006
PremiumThe Fly
Lexeo Therapeutics reaches FDA alignment on development plan for LX2006
1M ago
LXEO
Lexeo Therapeutics reports Q3 EPS (89c), consensus (68c)
PremiumThe Fly
Lexeo Therapeutics reports Q3 EPS (89c), consensus (68c)
1M ago
LXEO
Lexeo Therapeutics sees cash runway into 2027
PremiumThe Fly
Lexeo Therapeutics sees cash runway into 2027
1M ago
LXEO
Lexeo Therapeutics announces positive results from Phase 1/2 study of LX1001
PremiumThe FlyLexeo Therapeutics announces positive results from Phase 1/2 study of LX1001
2M ago
LXEO
Lexeo Therapeutics to present interim data from Phase 1/2 trial of LX1001
Premium
The Fly
Lexeo Therapeutics to present interim data from Phase 1/2 trial of LX1001
2M ago
LXEO
Lexeo Therapeutics price target lowered to $21 from $22 at H.C. Wainwright
Premium
The Fly
Lexeo Therapeutics price target lowered to $21 from $22 at H.C. Wainwright
4M ago
LXEO
Lexeo Therapeutics reports Q2 EPS (64c), consensus (69c)
PremiumThe Fly
Lexeo Therapeutics reports Q2 EPS (64c), consensus (69c)
4M ago
LXEO
Lexeo Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
Lexeo Therapeutics participates in a conference call with JPMorgan
5M ago
LXEO
Lexeo Therapeutics reports ‘positive’ results from LX2006 study
PremiumThe Fly
Lexeo Therapeutics reports ‘positive’ results from LX2006 study
5M ago
LXEO
Lexeo Therapeutics to report interim Phase 1/2 clinical data of LX2006
PremiumThe Fly
Lexeo Therapeutics to report interim Phase 1/2 clinical data of LX2006
5M ago
LXEO
Lexeo Therapeutics Welcomes New Board Member Tim Van Hauwermeiren
PremiumCompany AnnouncementsLexeo Therapeutics Welcomes New Board Member Tim Van Hauwermeiren
6M ago
8K
LXEO
Lexeo Therapeutics appoints Tim Van Hauwermeiren to board of directors
Premium
The Fly
Lexeo Therapeutics appoints Tim Van Hauwermeiren to board of directors
6M ago
ARGX
LXEO
Lexeo Therapeutics initiated with an Outperform at Baird
Premium
The Fly
Lexeo Therapeutics initiated with an Outperform at Baird
6M ago
LXEO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >